Mesenchymal stem cells (MSCs) are the specific cell type most commonly used in the regenerative treatments discussed throughout this site — worth understanding on their own terms as foundational background.
What MSCs actually are
MSCs are a type of adult stem cell capable of self-renewal and differentiation into several tissue types, including bone, cartilage, and fat cells. Unlike embryonic stem cells, MSCs are harvested from adult tissue sources — most commonly bone marrow or adipose (fat) tissue — which is why they're the primary cell type used in the orthopedic and aesthetic applications covered elsewhere on this site.
MSCs' properties — self-renewal, multi-tissue differentiation potential, and immunomodulatory effects — are what make them attractive for regenerative applications. Understanding this basic biology helps make sense of why they're used across such a range of conditions, from orthopedic to autoimmune applications.
Where MSCs are sourced from
See our sourcing comparison guide for the trade-offs between bone marrow and adipose-derived MSCs — the two most common sources used in clinical practice.
How MSCs are believed to work therapeutically
- Direct differentiation — in some applications, contributing directly to new tissue formation
- Immunomodulation — influencing inflammatory processes in ways that may support healing
- Paracrine signaling — releasing molecules that support surrounding tissue's own healing processes (a mechanism shared with exosome therapy, see our comparison guide)
Why this foundational understanding matters
Understanding the actual biology helps you evaluate specific treatment claims more critically — a claim that doesn't align with known MSC biology is worth questioning, regardless of how confidently it's presented.
Ready to talk to someone?
Message us on WhatsApp for a free, no-obligation consultation.